Guardant Health [GH] vs Danaher [DHR] Detailed Stock Comparison

Guardant Health Inc.

NASDAQ
Loading...

Danaher Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Guardant Health Inc. wins in 3 metrics, Danaher Corporation wins in 16 metrics, with 0 ties. Danaher Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Guardant Health Inc. Danaher Corporation Better
P/E Ratio (TTM) -26.47 34.61 Danaher Corporation
Price-to-Book Ratio -113.87 2.40 Danaher Corporation
Debt-to-Equity Ratio -17.22 37.17 Danaher Corporation
PEG Ratio -2.38 3.84 Danaher Corporation
EV/EBITDA -31.17 17.69 Danaher Corporation
Profit Margin (TTM) -42.39% 14.89% Danaher Corporation
Operating Margin (TTM) -42.91% 22.94% Danaher Corporation
EBITDA Margin (TTM) N/A 22.94% N/A
Return on Equity 419.18% 7.08% Guardant Health Inc.
Return on Assets (TTM) -15.59% 4.19% Danaher Corporation
Free Cash Flow (TTM) $-233.07M $5.26B Danaher Corporation
Dividend Yield N/A 0.56% N/A
1-Year Return 167.03% -10.25% Guardant Health Inc.
Price-to-Sales Ratio (TTM) 12.07 5.10 Danaher Corporation
Enterprise Value $12.36B $140.38B Danaher Corporation
EV/Revenue Ratio 12.59 5.67 Danaher Corporation
Gross Profit Margin (TTM) 64.63% 60.34% Guardant Health Inc.
Revenue per Share (TTM) $8 $35 Danaher Corporation
Earnings per Share (Diluted) $-3.32 $5.16 Danaher Corporation
Beta (Stock Volatility) 1.65 0.99 Danaher Corporation
Short % of Float 10.93% 1.10% Danaher Corporation

Guardant Health Inc. vs Danaher Corporation Stock Performance Analysis

Loading Price Chart...

GH
DHR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Guardant Health Inc.-1.37%3.95%36.77%48.91%26.44%27.60%
Danaher Corporation0.56%-1.32%11.85%-5.38%-20.75%-21.40%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Guardant Health Inc.167.03%254.87%9.50%350.75%350.75%350.75%
Danaher Corporation-10.25%-15.98%-20.94%174.08%416.93%738.84%

Performance & Financial Health Analysis: Guardant Health Inc. vs Danaher Corporation

MetricGHDHR
Market Information
Market Cap i$11.53B$126.39B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i2,518,2325,174,666
90 Day Avg. Volume i2,085,5574,357,215
Last Close$129.82$181.10
52 Week Range$40.35 - $135.00$160.93 - $242.80
% from 52W High-3.84%-25.41%
All-Time High$181.07 (Feb 08, 2021)$296.06 (Sep 06, 2021)
% from All-Time High-28.30%-38.83%
Growth Metrics
Quarterly Revenue Growth0.39%0.04%
Quarterly Earnings Growth0.39%0.08%
Financial Health
Profit Margin (TTM) i-0.42%0.15%
Operating Margin (TTM) i-0.43%0.23%
Return on Equity (TTM) i4.19%0.07%
Debt to Equity (MRQ) i-17.2237.17
Cash & Liquidity
Book Value per Share (MRQ)$-0.76$74.32
Cash per Share (MRQ)$9.16$8.06
Operating Cash Flow (TTM) i$-184,760,000$6.44B
Levered Free Cash Flow (TTM) i$-88,105,872$4.57B
Dividends
Last 12-Month Dividend Yield iN/A0.56%
Last 12-Month Dividend iN/A$1.28

Valuation & Enterprise Metrics Analysis: Guardant Health Inc. vs Danaher Corporation

MetricGH (Apr 24, 2026)DHR (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-26.4734.61
Forward P/E i-129.0819.64
PEG Ratio i-2.383.84
Price to Sales (TTM) i12.075.10
Price to Book (MRQ) i-113.872.40
Market Capitalization
Market Capitalization i$11.53B$126.39B
Enterprise Value i$12.36B$140.38B
Enterprise Value Metrics
Enterprise to Revenue i12.595.67
Enterprise to EBITDA i-31.1717.69
Risk & Other Metrics
Beta i1.650.99
Book Value per Share (MRQ) i$-0.76$74.32

Financial Statements Comparison: Guardant Health Inc. vs Danaher Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricGH (2025)DHR (2025)
Revenue/Sales i982.02M24.57B
Cost of Goods Sold i349.01M10.05B
COGS % of Revenue i35.5%40.9%
Gross Profit i633.01M14.52B
Gross Margin i64.5%59.1%
Research & Development i364.19M1.60B
Operating Income (EBIT) i-437.25M4.69B
Operating Margin i-44.5%19.1%
EBITDA i-373.91M7.17B
EBITDA Margin i-38.1%29.2%
Pre-Tax Income i-417.54M4.23B
Pre-Tax Income % of Revenue i-42.5%17.2%
Income Tax i-1.26M633.00M
Income Tax % of Revenue i-0.1%2.6%
Net Income (Profit) i-416.28M3.61B
Profit Margin i-42.4%14.7%

Balance Sheet & Liquidity Metrics

MetricGH (2025)DHR (2025)
Cash & Equivalents i378.20M4.62B
Total Current Assets i1.47B12.76B
Total Current Assets % of Revenue i149.3%51.9%
Total Current Liabilities i302.73M6.81B
Total Current Liabilities % of Revenue i30.8%27.7%
Long-Term Debt i1.68B19.50B
Long-Term Debt % of Revenue i171.3%79.4%
Total Shareholders Equity i-99.31M52.54B
Retained Earnings i-2.99B46.89B
Retained Earnings % of Revenue i-304.9%190.9%
Property, Plant & Equipment i158.85M2.14B

Cash Flow Statement Comparison

MetricGH (2025)DHR (2025)
Operating Cash Flow i-230.19M5.64B
Operating Cash Flow % of Revenue i-23.4%23.0%
Capital Expenditures i-48.31M-1.12B
Free Cash Flow i-233.07M5.26B
FCF Margin i-23.7%21.4%
Debt Repayment iN/A-500.00M
Common Stock Repurchase i-45.01M-3.09B

Short Interest & Institutional Ownership Analysis

MetricGHDHR
Shares Short i13.70M6.94M
Short Ratio i7.501.68
Short % of Float i10.93%1.10%
Shares Outstanding i130.64M707.70M
Float Shares i125.75M630.65M
% Held by Insiders i4.04%10.78%
% Held by Institutions i101.22%85.08%
% Held by Public i-5.26%4.14%

Dividend Analysis & Yield Comparison: Guardant Health Inc. vs Danaher Corporation

MetricGHDHR
Last 12-Month Dividend iN/A$1.28
Last 12-Month Dividend Yield iN/A0.56%
3-Year Avg Annual Dividend iN/A$10.51
3-Year Avg Dividend Yield iN/A1.11%
3-Year Total Dividends iN/A$31.54
Ex-Dividend DateN/ADec 26, 2025